South African tycoon Stephen Saad's Aspen stake climbs to $599 million
Aspen Pharmacare co-founder Stephen Saad's 13% stake has climbed to R9.94 billion as analysts lift their average price target on the drugmaker to R175.
Pharmaceuticals
Nigerian tycoon Fidelis Ayebae’s Fidson Healthcare lifts nine-month profit 47% as currency losses vanish
Nigerian tycoon Fidelis Ayebae’s Fidson Healthcare lifted nine-month profit 47% to N11.74 billion as revenue rose 21% and currency losses nearly vanished.
Egyptian pharma tycoon Ahmed Abu Al-Naga sells half of ATCO for $50 million
Private equity firm RMBV is taking 50% of ATCO Pharma, the Egyptian drugmaker run by Ahmed Abu Al-Naga, in a $50 million deal.
South African pharma tycoon Stephen Saad's Aspen shares gain $142 million in 2026
Aspen Pharmacare's founder holds shares worth $558.7 million after a 34% rally this year, yet the stake remains $1 billion below its 2015 peak.
Ugandan pharma tycoon Emmanuel Katongole quits tax board after six months
Emmanuel Katongole, co-founder of Ugandan HIV drug maker Quality Chemical Industries, has resigned as chairman of Uganda's tax authority board after six months.
South African tycoon Stephen Saad's Aspen pulls out of making the HIV prevention shot
Aspen has withdrawn from South Africa's plan to make Gilead's HIV prevention injection locally, with Stephen Saad citing the absence of purchase guarantees.